FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109850844> ?p ?o ?g. }

• W2109850844 endingPage "355" @default.
• W2109850844 startingPage "349" @default.
• W2109850844 abstract "Purpose To assess whether preoperative plasma levels of urokinase-type plasminogen activator (uPA) and its soluble receptor (uPAR) would predict cancer of the prostate (CaP) presence, stage, and prognosis. Patients and Methods Plasma levels of uPA and uPAR were measured in patients who underwent radical prostatectomy for clinically localized CaP (preoperative, n = 429; postoperative, n = 76), 44 healthy men, 19 patients with metastases to regional lymph nodes, and 10 patients with bone metastases. Results uPA and uPAR levels were significantly elevated in patients with CaP compared with healthy men and significantly declined after prostate removal. In CaP patients, uPA and uPAR levels both increased significantly from patients with nonmetastatic CaP to patients with lymph node metastases to patients with skeletal metastases. On univariate analysis, preoperative uPA and uPAR levels were significantly elevated in patients with extracapsular extension, seminal vesicle involvement, higher prostatectomy Gleason sum, lymph node invasion, lymphovascular invasion, perineural invasion, and higher tumor volume. Higher preoperative uPAR was associated with biochemical progression in univariate analysis. Conversely, higher preoperative uPA was independently associated with biochemical progression in preoperative or postoperative multivariate models. In patients with biochemical progression, preoperative uPA and uPAR were both significantly associated with shorter postprogression total serum prostate-specific antigen doubling times, failure to respond to salvage local radiation therapy, and/or development of distant metastasis. Conclusion Elevation of plasma uPA and uPAR levels in CaP patients seems to be partly caused by local release from the prostate. Plasma levels of uPA and uPAR are associated with features of biologically aggressive CaP, disease progression after radical prostatectomy, and metastasis." @default.
• W2109850844 created "2016-06-24" @default.
• W2109850844 creator A5026543640 @default.
• W2109850844 creator A5034888871 @default.
• W2109850844 creator A5037470251 @default.
• W2109850844 creator A5045482204 @default.
• W2109850844 creator A5049019006 @default.
• W2109850844 creator A5058375255 @default.
• W2109850844 creator A5079401169 @default.
• W2109850844 date "2007-02-01" @default.
• W2109850844 modified "2023-10-18" @default.
• W2109850844 title "Association of the Circulating Levels of the Urokinase System of Plasminogen Activation With the Presence of Prostate Cancer and Invasion, Progression, and Metastasis" @default.
• W2109850844 cites W1470345216 @default.
• W2109850844 cites W1986388027 @default.
• W2109850844 cites W2005113904 @default.
• W2109850844 cites W2014438829 @default.
• W2109850844 cites W2017631249 @default.
• W2109850844 cites W2024550668 @default.
• W2109850844 cites W2028490093 @default.
• W2109850844 cites W2059075122 @default.
• W2109850844 cites W2061879006 @default.
• W2109850844 cites W2064387750 @default.
• W2109850844 cites W2065727101 @default.
• W2109850844 cites W2067298047 @default.
• W2109850844 cites W2073339156 @default.
• W2109850844 cites W2074470637 @default.
• W2109850844 cites W2121799544 @default.
• W2109850844 cites W2155498341 @default.
• W2109850844 cites W2395111376 @default.
• W2109850844 cites W2398661098 @default.
• W2109850844 cites W2415407395 @default.
• W2109850844 cites W2417303506 @default.
• W2109850844 cites W2444070421 @default.
• W2109850844 doi "https://doi.org/10.1200/jco.2006.05.6853" @default.
• W2109850844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17264329" @default.
• W2109850844 hasPublicationYear "2007" @default.
• W2109850844 type Work @default.
• W2109850844 sameAs 2109850844 @default.
• W2109850844 citedByCount "189" @default.
• W2109850844 countsByYear W21098508442012 @default.
• W2109850844 countsByYear W21098508442013 @default.
• W2109850844 countsByYear W21098508442014 @default.
• W2109850844 countsByYear W21098508442015 @default.
• W2109850844 countsByYear W21098508442016 @default.
• W2109850844 countsByYear W21098508442017 @default.
• W2109850844 countsByYear W21098508442018 @default.
• W2109850844 countsByYear W21098508442019 @default.
• W2109850844 countsByYear W21098508442020 @default.
• W2109850844 countsByYear W21098508442021 @default.
• W2109850844 countsByYear W21098508442022 @default.
• W2109850844 countsByYear W21098508442023 @default.
• W2109850844 crossrefType "journal-article" @default.
• W2109850844 hasAuthorship W2109850844A5026543640 @default.
• W2109850844 hasAuthorship W2109850844A5034888871 @default.
• W2109850844 hasAuthorship W2109850844A5037470251 @default.
• W2109850844 hasAuthorship W2109850844A5045482204 @default.
• W2109850844 hasAuthorship W2109850844A5049019006 @default.
• W2109850844 hasAuthorship W2109850844A5058375255 @default.
• W2109850844 hasAuthorship W2109850844A5079401169 @default.
• W2109850844 hasBestOaLocation W21098508441 @default.
• W2109850844 hasConcept C121608353 @default.
• W2109850844 hasConcept C126322002 @default.
• W2109850844 hasConcept C126894567 @default.
• W2109850844 hasConcept C143998085 @default.
• W2109850844 hasConcept C144301174 @default.
• W2109850844 hasConcept C2776235491 @default.
• W2109850844 hasConcept C2777008409 @default.
• W2109850844 hasConcept C2777154038 @default.
• W2109850844 hasConcept C2778740770 @default.
• W2109850844 hasConcept C2779013556 @default.
• W2109850844 hasConcept C2779466945 @default.
• W2109850844 hasConcept C2779679481 @default.
• W2109850844 hasConcept C2780192828 @default.
• W2109850844 hasConcept C2780849966 @default.
• W2109850844 hasConcept C2781406297 @default.
• W2109850844 hasConcept C38180746 @default.
• W2109850844 hasConcept C56219504 @default.
• W2109850844 hasConcept C71924100 @default.
• W2109850844 hasConceptScore W2109850844C121608353 @default.
• W2109850844 hasConceptScore W2109850844C126322002 @default.
• W2109850844 hasConceptScore W2109850844C126894567 @default.
• W2109850844 hasConceptScore W2109850844C143998085 @default.
• W2109850844 hasConceptScore W2109850844C144301174 @default.
• W2109850844 hasConceptScore W2109850844C2776235491 @default.
• W2109850844 hasConceptScore W2109850844C2777008409 @default.
• W2109850844 hasConceptScore W2109850844C2777154038 @default.
• W2109850844 hasConceptScore W2109850844C2778740770 @default.
• W2109850844 hasConceptScore W2109850844C2779013556 @default.
• W2109850844 hasConceptScore W2109850844C2779466945 @default.
• W2109850844 hasConceptScore W2109850844C2779679481 @default.
• W2109850844 hasConceptScore W2109850844C2780192828 @default.
• W2109850844 hasConceptScore W2109850844C2780849966 @default.
• W2109850844 hasConceptScore W2109850844C2781406297 @default.
• W2109850844 hasConceptScore W2109850844C38180746 @default.
• W2109850844 hasConceptScore W2109850844C56219504 @default.
• W2109850844 hasConceptScore W2109850844C71924100 @default.
• W2109850844 hasIssue "4" @default.
• W2109850844 hasLocation W21098508441 @default.

• next